Welcome
Support Centre
23 April 2014 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
MAESTRO: Multidisciplinary Aftercare for Elderly with STROke
ISRCTN ISRCTN62286281
DOI 10.1186/ISRCTN62286281
ClinicalTrials.gov identifier
EudraCT number
Public title MAESTRO: Multidisciplinary Aftercare for Elderly with STROke
Scientific title Effects of a patient-tailored multidisciplinary aftercare programme for elderly people discharged after rehabilitation in a nursing home: A multicentre randomised controlled trial
Acronym MAESTRO
Serial number at source 313070301
Study hypothesis The following principal research questions will be answered in the effect evaluation:
1. Can the transmural integrated care programme improve elderly stroke patientsí ability to live independently, functioning, social participation, perceived quality of life, and care and treatment burden, as compared to usual care?
2. Can the transmural integrated care programme reduce caregiver strain as compared to usual care?
Lay summary Not provided at time of registration
Ethics approval Ethical approval will be requested within a month
Study design Multicentre 2 arm interventional randomised controlled parallel group trial
Countries of recruitment Netherlands
Disease/condition/study domain Rehabilitation and aftercare after stroke
Participants - inclusion criteria 1. Admitted to a stroke unit
2. Aged 65 or older
Participants - exclusion criteria Unable to give informed consent
Anticipated start date 01/05/2010
Anticipated end date 31/12/2012
Status of trial Completed
Patient information material Not available in web format, please use contact details below to request a patient information sheet
Target number of participants 256; 128 patients per group
Interventions Patients randomised to the intervention group will participate in a new Transmural Integrated Care (TIC) programme delivered by a multidisciplinary team of primary and tertiary (nursing home) care practitioners. This team will include a nursing home physician and a GP, as well as a physiotherapist, an occupational therapist, a speech therapist, a social worker, a dietician, a psychologist and a care coordinator. The programme is aimed at both patients and their informal caregivers.
The TIC programme will start directly after it is decided that a patient can be discharged to return home. An individual treatment plan will facilitate the transition from in- to outpatient rehabilitation care and guide further home-based rehabilitation. Inpatientís goals for treatment will be continued during home-based rehabilitation. The TIC programme consists of two parts: a transition and reintegration phase.
This first part of the TIC programme will start during the patientís stay in the nursing home and will continue at home after discharge. In this period the patient will make the transition form nursing home to living in the community. Therefore this part of the programme will partly take place in the nursing home and partly in the patients' home. An individual discharge plan will be set up at the nursing home, directly after it is decided that the patient will be discharged to return home. It will include all activities needed to ensure further care and treatment, as well as activities to facilitate procedures for necessary home adaptations and assisting devices. The multidimensional health problems as a result of stroke, which can have major implications for patientsí functioning in terms of locomotion, communication, cognition and emotional condition, require care delivered in an individually planned rehabilitation programme. The main treatment aim in this part of the TIC programme will be to improve patientsí daily functioning and stimulate them to live independently at home. During training, the focus will be on (re)learning the abilities needed for individual patients to function independently in their home environments. The patient is offered a training which even during the patients stay in the nursing home will be partly performed in the patients home. This unique possibility to practice in the context of patientsí own environments will facilitate their return. An additional treatment goal in this first part of the TIC programme is to prepare patientsí partner or other person for their role as caregivers. The transition part will take on average 1.5 months The reintegration part of the programme starts directly after the transition part. During this part of the TIC programme, in which possibilities for further functional progress are limited, the accent of treatment will switch to learning to cope with residual impairments as a result of stroke. Both patients and caregivers will be trained in improving their coping strategies and empowerment techniques based on self-management principles. The main aim of treatment is to improve the performance of daily activities and participation in society.
Education and patient support will form an important part of the programme. In cooperation with the patient organisation, an information course will be organised consisting of five meetings. The course will focus on consequences of stroke, perceived problems in living independently and returning to society, and the new role of the partner as caregiver.
Throughout the programme, goal attainment scaling will be used for goal setting during treatment. Goal attainment scaling appeared to be an appropriate method as a guide for rehabilitation treatment for elderly people. Treatment progress will be evaluated through regular team meetings. To facilitate the TIC programme an electronic dossier will be used. The reintegration part will take on average 3.5 months. The mean duration of the program will be on average 5 months.

Patients randomised to the control group will receive usual care.

The total duration of follow up will be 12 months
Primary outcome measure(s) 1. Patients:
1.1. Daily activity, measured using the Frenchay Activity Index questionnaire
1.2. Level of functioning, measured using the Katz-15 questionnaire
1.3. Perceived quality of life, measured using the Stroke Specific Quality of Life Questionnaire
1.4. Participation, measured using the Impact on Participation and Autonomy questionnaire
2. Informal caregivers:
2.1. Objective informal caregivers' care load, measured using the Erasmus iBMG questionnaire
2.2. Perceived informal caregivers' care load, measured using the Self-Rated Burden Visual Analogue Scale and the Carer Quality Of Life questionnaire
2.3. Perceived quality of life, measured using the RAND-36 questionnaire
2.4. Perceived health, measured using the RAND-36 questionnaire
All outcomes will be measured at baseline, 6 months and 12 months
Secondary outcome measure(s) Patients:
1. Perceived health
2. Mental wellbeing
3. Social functioning
All outcomes measured at baseline, 6 months and 12 months using the RAND-36 questionnaire
Sources of funding Netherlands Organisation for Health Research and Development (ZonMw) (Netherlands) - (grant number: 313070301)
Trial website
Publications 1. 2013 protocol in http://www.ncbi.nlm.nih.gov/pubmed/23273217
Contact name Dr  Jolanda  van Haastregt
  Address Universiteitssingel 40
P.O. Box 616
6200 MD Maastricht
The Netherlands
  City/town Maastricht
  Zip/Postcode 6229 HR
  Country Netherlands
Sponsor Netherlands Organisation for Health Research and Development (ZonMw) (Netherlands)
  Address Laan van Nieuw Oost-Indië 334
  City/town Den Haag
  Zip/Postcode 2593 CE
  Country Netherlands
  Sponsor website: http://ww.zonmw.nl
Date applied 19/03/2010
Last edited 28/06/2013
Date ISRCTN assigned 18/05/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2014 ISRCTN unless otherwise stated.